Vance Terry 4
4 · ENANTA PHARMACEUTICALS INC · Filed Mar 7, 2022
Insider Transaction Report
Form 4
Vance Terry
Director
Transactions
- Award
Stock Option (right to buy)
2022-03-03+7,500→ 7,500 totalExercise: $68.22Exp: 2032-03-03→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 3, 2022), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2023 annual meeting of stockholders.